TNF and infection: International consensus statements do not mandate antifungal prophylaxis for IL-12/23 inhibitors, reflecting comparatively low serious infection risks versus tumor necrosis factor-alpha (TNF-α) inhibitors; nonetheless, individualized risk assessment is advised [14].